nutrigenomics

(redirected from nutragenomics)
Also found in: Dictionary.

nutrigenomics

(no͞o′trə-jə-nō′mĭks, nyo͞o′-)
n. (used with a sing. verb)
The study of how the genome and diet interact to influence human and animal health and disease.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.

nu·tri·ge·no·mics

(nū'tri-jē-nō'miks)
The study of how diet influences gene expression, and thus, health.
Synonym(s): nutragenomics, nutritional genomics.
[nutri- + genomics]
Medical Dictionary for the Health Professions and Nursing © Farlex 2012

nutrigenomics

The use of knowledge of an individual's genetic makeup to devise a personally appropriate eating strategy. Also known as “personalized nutrition.”
Medical Dictionary, © 2009 Farlex and Partners

nutrigenomics

analysis of the effects of nutrient intake on gene function and health, by using such approaches as GENOMICS, METABOLOMICS, PROTEOMICS and TRANSCRIPTOMICS. Genetic variations affect how the body utilizes nutrients and removes toxins. An understanding of an individual's genotype should enable diets to be tailored to meet specific genetic needs and new foods developed for personalized health and nutritional benefit.
Collins Dictionary of Biology, 3rd ed. © W. G. Hale, V. A. Saunders, J. P. Margham 2005
References in periodicals archive ?
Number of newspaper articles on nutrigenomics that refer to a nutrigenomics company Nutrigenomics Company Number of Newspaper Articles Genelex 29 Sciona 17 Consumer Genetics 14 NutraGenomics 11 One Person Health 8 Healthcheck USA 7 Genecare 5 Alphagenics 5 WellGen 3 DNA Diet 2 Metagenics 2 Suracell 1 Nutrigen 0 Salugen 0
That's because a single base pair change in DNA occurred in northern Europe about 6,500-12,000 years ago, which allowed people there to digest lactose--in an environment with a short growing season, access to the additional nutritious food source of milk was helpful for survival, says Jim Kaput, a pioneer of nutrigenomics and founder of the diagnostics company NutraGenomics.
WellGen, Inc., New Brunswick, NJ, a biotechnology company using nutragenomics to develop wellness products from plants that alter the expression of genes responsible for human disease, has received $3 million in the form of equity capital, through a private offering of preferred stock, from venture-capital investors led by Amphion Capital Partners LLC, New York, NY.
This session will discuss nutragenomics and how it will create an intensely competitive new environment for business in the future.
Increased consumer awareness, changes in our healthcare paradigm and technology advances such as nutragenomics will make major impacts on the future of this industry."